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ABSTRACT
Massive high-throughput sequencing techniques al-
lowed the identification of thousands of noncoding
RNAs (ncRNAs) and a plethora of different mRNA
processing events occurring in higher organisms.
Long ncRNAs can act directly as long transcripts
or can be processed into active small si/miRNAs.
They can modulate mRNA cleavage, translational re-
pression or the epigenetic landscape of their tar-
get genes. Recently, certain long ncRNAs have been
shown to play a crucial role in the regulation of alter-
native splicing in response to several stimuli or dur-
ing disease. In this review, we focus on recent discov-
eries linking gene regulation by alternative splicing
and its modulation by long and small ncRNAs.
INTRODUCTION
Eukaryotic genes are often discontinuous with noncoding
(intronic sequences) and coding DNA (exonic sequences).
Therefore, in order to produce a mature mRNA that can
be translated into a protein, introns need to be removed
and exons joined by a process called splicing. In certain cir-
cumstances, splicing reactions can be modulated generating
two or more mRNA isoforms from a single pre-mRNA by
a process called alternative splicing (AS). In recent years,
improvements in our ability to sequence entire genomes
and complete pools of transcripts allowed the identifica-
tion of a plethora of different mRNA isoforms in higher
organisms. More than 90% of intron-containing genes in
humans and over 60% in plants, are alternatively spliced
in controlled conditions (1–4). The significant diversity in
the number of transcripts in comparison to the number of
genes emphasizes the extensive regulation occurring at tran-
scriptional and post-transcriptional levels (5). Many genes
have been found to produce tissue or condition-dependent
isoforms (6). In humans, numerous studies point out a link
between RNA splicing misregulation and several diseases
(7–10). In plants, under stress conditions, AS plays an im-
portant role in the control of gene expression for an ade-
quate response (11–14). Interestingly, the identification of
alternatively spliced transcripts revealed a high number of
genes encoding multiple proteins which may perform rel-
evant functions in gene expression, as splicing regulators
and transcription factors (15–20). In fact, some AS features
seemed to be conserved across species and indeed genes ho-
mologous to common splicing regulators are also conserved
(20). Growing evidence indicates that AS is an important
mechanism that controls gene expression by (i) increasing
gene-coding capacities, thus proteome complexity through
the generation of different mRNA isoforms, and/or (ii) fa-
cilitating mRNA degradation through the introduction of
a premature termination codon in specific isoforms that
would lead to non-sense mediated decay (NMD).
Recognition of the splicing site can be modulated by cis-
regulatory sequences, known as splicing enhancers or si-
lencers, which contribute to the generation of two or more
alternatively-spliced mRNAs from the same pre-mRNA.
Computational analyses on genome-wide RNA sequencing
have allowed the identification of splicing patterns in dif-
ferent organisms under various specific conditions, show-
ing the dynamic nature of AS regulation in gene expression
(21–23). AS defects are also related to various diseases in
mammals (for review see, (24–26)), and to perturbations of
plant responses to environmental cues (11,17,27,28).
Besides the identification of numerous AS events on mR-
NAs, next generation sequencing technologies have facil-
itated the identification of thousands of RNAs with no
or low coding potential (the so-called noncoding RNAs,
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ncRNAs). Globally, ncRNAs are classified by their size.
The long ncRNAs (lncRNAs, over 200 nt) act directly in
a long form by lncRNA-protein interactions, whereas the
small ncRNAs (smRNAs) act by smRNA-protein interac-
tions and base paring recognition of their mRNA targets.
They were found to be modulated by different stimuli, ex-
erting regulatory roles in gene expression by their implied
involvement in mRNA cleavage, translational repression or
epigenetic DNA/chromatin modification of their targets,
hence leading to a wide range of biological outputs required
for cell viability and function (29–31). It has been known
for a long time that splicing mechanisms are regulated by
small ncRNAs named nuclear uridine (U)-rich RNAs (U
snRNAs). This group of noncoding RNAs catalyze each
step of the splicing reaction (for review, (32)) in collabo-
ration with core small nuclear ribonucleoprotein complex
subunits (snRNPs), whereas more than 200 non-snRNPs
splicing factors (SFs) (33–35) fine-tune complex splicing
regulations.
Recently, a growing number of ncRNAs have emerged as
modulators ofAS of specific genes. In this review, we discuss
our current knowledge of long and small ncRNAs identified
as splicing regulators and their mechanisms of action.
REGULATION OF ALTERNATIVE SPLICING BY LONG
NONCODING RNAs
In the last few years, the identification of large amounts
of lncRNAs induced or repressed in particular conditions
or diseases suggested their possible implication in a wide
range of biological processes. Detailed studies of some of
them in different eukaryotic organisms have uncovered sev-
eral lncRNA-mediated mechanisms fine-tuning almost ev-
ery step of gene expression, including chromatin remodel-
ing, transcriptional control, co-and posttranscriptional reg-
ulation, miRNA processing, and protein stability during
different developmental processes (36–40). In particular, a
growing number of lncRNAs have been linked to the modu-
lation of AS in both plants and animals (Table 1). The main
mechanisms involving lncRNAs in AS modulation can be
classified in three ways: (i) lncRNAs interacting with spe-
cific SFs; (ii) lncRNAs forming RNA-RNA duplexes with
pre-mRNA molecules and (iii) lncRNAs affecting chro-
matin remodelling, thus fine-tuning the splicing of target
genes. Sub-classifications based on similarities and differ-
ences among mechanisms are proposed below.
LONG NONCODING RNAs AS SPLICING FACTOR IN-
TERACTORS
One of the first presumptions of the role of lncR-
NAs in splicing was given by a genome-wide screen-
ing in human and mouse cells that identified, in both
cases, the following nuclear noncoding transcripts: NU-
CLEAR PARASPECKLE ASSEMBLY TRANSCRIPT 1
(NEAT1) andNUCLEAR PARASPECKLE ASSEMBLY
TRANSCRIPT 2 (NEAT2) / METASTASIS ASSOCI-
ATED LUNG ADENOCARCINOMA TRANSCRIPT 1
(MALAT1). RNA FISH analyses revealed an intimate as-
sociation of NEAT1 and MALAT1 with the SC35 SF-
containing nuclear speckles in both human andmouse cells,
suggesting their participation in mRNA splicing. These
studies also showed that NEAT1 localizes to the speckles
periphery, whereasMALAT1 is part of the polyadenylated
component of nuclear speckles (41). More recently, fur-
ther nuclear-localized lncRNAs were linked to splicing reg-
ulation both in animals (e.g. GOMAFU, SAF) and plants
(e.g.ASCO), whereas other lncRNAs have been found both
in the nucleus and the cytoplasm (e.g. LINC01133 and
ENOD40). Among them, a subset of lncRNAs seems recog-
nized by SFs, impacting their activity in two ways: (i) mod-
ulating their posttranslational modifications (e.g. phospho-
rylation), or (ii) regulating the interaction with other SFs,
and/or with protein-coding (pre)mRNAs.
NEAT1 and MALAT1/NEAT2 regulate the phosphoryla-
tion status of splicing factors
Serine/arginine-rich (SR) proteins are a conserved fam-
ily of proteins largely involved in splicing. These proteins
are composed of two domains, the RNA recognition motif
(RRM) and the SRdomain (42). SR proteins are commonly
localized in the nucleus, although several of them are known
to shuttle between the nucleus and the cytoplasm. Basically,
a continuous phosphorylation/dephosphorylation cycle of
SR proteins is required for proper pre-mRNA splicing and
the regulation of AS patterns. The hyperphosphorylation
of the SR domain influences the binding of SR proteins to
target pre-mRNA, impacting the splice site selection. Par-
tially dephosphorylated SR proteins support the first steps
of the transesterification reactions (43–45). Also, intranu-
clear trafficking of SR proteins between nuclear speckles
and transcription sites is dependent on their phosphoryla-
tion status (46,47). Thus, it is of paramount importance to
better understand how lncRNAs may modulate SR phos-
phorylation, thus affecting AS determination of SR targets.
NEAT1 is a highly abundant 4 kb lncRNA found in
paraspeckles, nuclear domains that control sequestration
of related proteins. NEAT1 accumulation is dynamically
regulated during adipocyte differentiation, modulating the
AS profile of PPARγ mRNA into both isoforms, PPARγ 1
and PPARγ 2, which code for the major transcription fac-
tor driving adipogenesis. The SR protein SRp40 (SFRS5)
is involved in the regulation of PPARγ 2 splicing. Dur-
ing differentiation, SRp40 levels are significantly increased
when the splicing of PPARγ 2 is induced. PPARγ mRNA
splicing regulation by SRp40 is modulated by its phos-
phorylation status determined by the Clk kinase (48). It
was demonstrated that SRp40 directly recognizes NEAT1,
exhibiting a dynamic association throughout differentia-
tion. NEAT1 depletion causes a decrease of PPARγ 1 and
PPARγ 2, in particular the PPARγ 2 isoform. The siRNA-
directed NEAT1 depletion impaired the cells ability to
phosphorylate SRp40. Furthermore, siRNA treatment for
SRp40 resulted in deregulation of PPARγ 1 and, primar-
ily, PPARγ 2 mRNA levels, whereas the overexpression of
SRp40 increased PPARγ 2, but not PPARγ 1. Therefore, it
was proposed that an increased concentration of phospho-
rylated SRp40 protein is present after being released from
NEAT1, promoting the splicing of PPARγ 2. This NEAT1-
dependent mechanism fine-tunes the relative abundance of
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Table 1. Developmental processes and diseases related to splicing-associated lncRNAs from the animal (background in red) and plant (in green) kingdoms
mRNA isoforms of key genes during adipogenesis (49) (Fig-
ure 1i).
The lncRNA MALAT1 (NEAT2) acts as an oncogene
transcript and its aberrant expression is involved in the de-
velopment and progression of many types of cancers (50–
52). Also, its accumulation was found to be associated with
cancer patient resistance to chemotherapy and radiother-
apy (53,54). Studies on human cells indicate thatMALAT1
regulates splicing bymodulating SR splicing factor distribu-
tion and phosphorylation (55). The depletion ofMALAT1
enhances the dephosphorylated pool of SR proteins, dis-
playing a more homogeneous nuclear distribution and re-
sulting in the mislocalization of speckle components and
changes in AS of pre-mRNAs. It was proposed that the ob-
served changes inAS of endogenous pre-mRNAs could be a
consequence of the mislocalization of pre-mRNA process-
ing factors, assuming a critical role exerted byMALAT1 in
the shuttling of SR proteins between speckles and the sites
of transcription. The control of the levels of phosphory-
lated SR proteins impacts not only AS but also likely reg-
ulates other SR-dependent post-transcriptional regulatory
mechanisms, including RNA export, NMD and translation
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Figure 1. Long noncoding RNAs regulate the phosphorylation status of splicing factors. (i) NEAT1 (blue) modulates SRp40 phosphorylation status
by interaction with the Clk kinase. Phosphorylated SRp40 promotes the processing of the PPARy pre-mRNA into the PPARy2 mRNA, whereas the
dephosphorylation of SRp40 favors the accumulation of the PPARy1 isoform. ( ii)MALAT1 (red) was proposed to modulate the phosphorylation status
of SR proteins in the nucleus, including the MALAT1-interacting SRSF1, likely by interaction with PP1/2A phosphatases or with the SRPK1 kinase.
Phosphorylated SRSF1 is accumulated in nuclear speckles (NS), whereas its dephosphorylation promotes the interaction with mRNAs (green), their
transport and accumulation in the cytoplasm, likely affecting also protein translation and/or incorporation into P-bodies (PB) hosting the non-sense
mediated decay (NMD) machinery. The three question marks indicate that each step was proposed albeit non validated.
(42,56). Interestingly, it was shown thatMALAT1-depleted
cells exhibit an increased cytoplasmic pool of poly(A)+
RNA, likely due to the altered cellular levels of dephos-
phorylated splicing factor SRSF1. It was previously shown
that dephosphorylation of SRSF1 is critical for the ex-
port of mRNA associated proteins (mRNPs) and is also
known to enhance binding of SRSF1 to mRNAs in the cy-
toplasm (57,58). Furthermore, in hepatocellular carcinoma,
MALAT1 oncogenic activity relies on the indirect modula-
tion of AS by transcriptional induction of SRSF1 (51). This
induction leads to the over accumulation of active SRSF1
in the cell nucleus and the modulation of SRSF1 splicing
targets, including the production of anti-apoptotic AS iso-
forms of S6K1 (51). However, the precise mechanisms by
which MALAT1 depletion alters the ratios of phosphory-
lated to dephosphorylated SR proteins in the cell remain
largely unknown (55). Possibly,MALAT1modulates the ac-
tivity of kinases (SRPKs or Clk/STY family), or of phos-
phatases (PP1 or PP2A), thatmodify SR proteins (56). Both
SRPK1 and PP1 influence AS by regulating SR protein
phosphorylation (59,60). Interestingly, the localization of
SRPK1 is altered inMALAT1-depleted cells, indicating the
potential involvement of MALAT1 in SRPK1 localization
and activity. Alternatively, SR protein stabilitymay bemod-
ulated by direct interaction withMALAT1, considering the
increased cellular levels of SR proteins and the changes ob-
served in AS patterns exhibited byMALAT1-depleted cells
(55) (Figure 1ii).
Long noncoding RNAs as splicing factor hijackers
The growth of cancer cells is promoted by the proto-
oncogene PTBP2 (POLYPYRIMIDINE TRACT-
BINDING PROTEIN 2; 61,62). SFPQ (proline- and
glutamine-rich SF; or PSF for PTB-associated SF) is
considered a tumor suppressor gene, which regulates the
tumor-promoting effects of PTBP2 by direct protein–
protein interaction (63–65). More recently, it was demon-
strated that MALAT1 is directly recognized by SFPQ,
but not by PTBP2, likely disrupting a splicing regulator
complex containing this tumor suppressor (66). Consid-
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ering that SFPQ contains two RNA-binding domains,
it was proposed that MALAT1 or other lncRNAs may
hijack SFPQ to partially inhibit the interaction between
SFPQ and PTBP2, affecting the regulatory role of SFPQ
on PTBP2 (67,68). The resulting release of PTBP2 from
the SFPQ-PTBP2 complex would allow the promotion of
tumor growth and metastasis (66) (Figure 2i).
Recently, a SF-interacting lncRNA was also reported in
cancer disease. The lncRNA LINC01133 shows a tissue-
and organ-specific expression pattern and was linked to dif-
ferent cancers (69,70). ThisLINC01133RNA is directly rec-
ognized by the AS factor SRSF6. LINC01133 expression
inhibits metastasis in a SRSF6-dependent manner. It was
proposed that LINC01133 acts as a target mimic to titrate
SRSF6 action on other mRNA substrates, leading to the in-
hibition of epithelial-mesenchymal transition and metasta-
sis in colorectal cancer cells (69). Thus, this lncRNA mod-
ulates SRSF6 activity as a decoy element of AS, in order
to shape the population of AS isoforms of SRSF6 mRNA
targets. Another example of SF-associated lncRNA is GO-
MAFU, which was involved in schizophrenia-associatedAS
(71). GOMAFU is expressed in a specific group of neu-
rons in adult mice and has been implicated in retinal cell
development (72,73), brain development (74) and post-
mitotic neuronal function (75,76). GOMAFU’s downregu-
lation leads to aberrant AS patterns, resembling those ob-
served in typically schizophrenia-associated genes likeDIS-
RUPTED IN SCHIZOPHRENIA 1 (DISC1) which ex-
erts a role in the neuronal system, as well as ERYTHROB-
LASTIC LEUKEMIA VIRAL ONCOGENEHOMOLOG
4 (ERBB4) implicated in mental illness (71).Moreover,GO-
MAFU was found to be downregulated in post-mortem
cortical gray matter from the superior temporal gyrus in
schizophrenia, suggesting that aberrant splicing patterns of
DISC1 and ERBB4 in schizophrenia could be mediated
by GOMAFU. Furthermore, GOMAFU was found to di-
rectly interact with the SFs QUAKING homolog QKI and
SRSF1 (71), likely modulating AS. QK1 and SRSF1 dereg-
ulation could lead to mental disorders such as schizophre-
nia. GOMAFU is also recognized through a tandem array
ofUACUAACmotifs by the splicing factor SF1, which par-
ticipates in the early stages of spliceosome assembly (77).
More recently, Celf3 (CUGBP Elav-like family member
3, also referred to as Tnrc4, Brunol1, CAGH4 or ERDA4;
reviewed in (78)) was also found to specifically interact with
GOMAFU. Interestingly, Celf3 forms novel nuclear bodies
(named CS bodies) in the neuroblastoma cell line Neuro2A,
colocalizing with the GOMAFU-interacting protein SF1.
However, GOMAFU was not observed in the CS bodies
but separately distributed throughout the nucleus. There-
fore, it was proposed that GOMAFU indirectly modulates
the function of RNA-binding proteins in CS bodies by se-
questering them to separate regions of the nucleus (79) (Fig-
ure 2ii).
Apart from cancer and neurological disorders, other dis-
eases may be related to AS modulated by lncRNAs. For
example, the 205 kb-lncRNA LINC-HELLP, which is im-
plicated in the pregnancy-associated disease HELLP, has
also been implicated in splicing regulation. LINC-HELLP
purification followed by mass spectrometry revealed that
this lncRNA is recognized by components of the splicing
and the ribosomal machineries, respectively (80), including
the splicing-related factors Y-BOX BINDING PROTEIN
1 (YBX1), and POLY(RC) BINDING PROTEINS 1 and
2 (PCBP1 and PCBP2). Although the molecular mecha-
nisms governing splicing regulation by LINC-HELLP re-
main largely unknown, it was demonstrated that upon the
occurrence of mutations in HELLP patients, the 5′-end up
to the middle of the LINC-HELLP transcript loses its abil-
ity to interact with its protein partners, whereas binding is
gained with mutations at the far 3′-end (80).
Small nucleolar RNAs (snoRNAs) are a family of con-
served nuclear RNAs located in Cajal bodies or nucleoli.
They participate in the modification of snRNAs or rRNA,
or participate in the processing of rRNA during ribosome
subunit maturation (81–83). SnoRNAs are processed from
excised and debranched introns by exonucleolytic trimming
(84). The snoRNA HBII-52 was implicated in the congen-
ital disease Prader-Willi syndrome (PWS), by modulating
the AS of the Serotonin Receptor 2C (85). More recently,
a novel class of nuclear-enriched intron-derived lncRNAs
was identified, which are processed on both ends by the
snoRNAmachinery (sno-lncRNAs). Sno-lncRNAs derived
from the PWS critical region of chromorome 15 are rec-
ognized by the FOX2 SF. It was proposed that these sno-
lncRNAs can recruit FOX proteins, regulating their avail-
ability for splicing of their targets. In patients suffering
PWS, particular sno-lncRNAs are deleted or not expressed.
As a result, FOX proteins are more uniformly distributed in
the cell nucleus, and modify the AS of specific genes during
early embryonic development and adulthood (84). An ad-
ditional sub-class of snoRNA-derived lncRNAs generated
from the PWS locus was recently identified. SPA lncRNAs
are snoRNA-5′ capped and 3′ polyadenylated accumulated
in the nucleus. They were shown to recruit key RNA bind-
ing proteins, such as TDP43, RBFOX2, and hnRNPM, in-
volved in multiple aspects of mRNAmetabolism regulation
(86). Therefore,SPA lncRNAs also fine-tune the availability
of RNA binding proteins, as the previously characterized
sno-lncRNAs (Figure 2iii).
In Arabidopsis thaliana, the lncRNA ASCO
(ALTERNATIVE SPLICING COMPETITOR) is recog-
nized in vivo by the plant-specific NUCLEAR SPECKLE
RNA-BINDING PROTEINS (NSRs), involved in splicing
(39). A transcriptomic dataset served to identify RNA
processing events in nsra/b double mutants using a bioin-
formatic approach. This analysis revealed an important
number of intron retention events and differential 5′
start or 3′ end in a subset of genes in the nsra/b mutant
compared to wild type plants (22). NSRs are positively
regulated by the phyto-hormone auxin, to which the nsra/b
mutant exhibits a decreased sensitivity, e.g. lower lateral
root number than wild type plants in response to auxin
treatment. This phenotype was related to the one observed
for ASCO overexpressing lines. Interestingly, the splicing
of a high number of auxin-related genes was perturbed in
nsra/b mutants and some of them behaved accordingly in
the ASCO overexpressing lines (39). An in vitro approach
showed that ASCO ‘competes’ with other mRNA-target
for its binding to the NSR regulators, suggesting that this
competition would modulate the affinity of NSRs for their
targets. The ASCO-NSR interaction could then regulate
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Figure 2. Long noncodingRNAs as splicing factor hijackers. ( i)MALAT1 can disrupt the formation of a splicingmodulator complex, by directly hijacking
the SFPQ factor, thus inhibiting its interaction with the tumor growth factor PTBP2. SFPQ-released PTBP2 promotes the proliferation of cancer cells.
(ii) Celf3 and SF1 normally co-localize in the CS nuclear bodies. GOMAFU lncRNA is recognized by both proteins, although it is not accumulated in CS
bodies. It was proposed that GOMAFU promotes the re-localization of Celf and SF1 out from CS bodies to the nucleoplasm, modulating their activity
in splicing. ( iii) SPA and sno-lncRNAs recruit RNA binding proteins such as FOX, TDP43 and hnRNP M, and may titrate their availability for splicing
regulation throughout the nucleus. In PWS patients SPA and sno-lncRNAs loci are deleted or not expressed, thus the related proteins are more uniformly
distributed, impacting the AS pattern of their target genes. (iv) ASCO lncRNA is directly recognized by NSRa and b, competing with their binding to
NSR-targeted pre-mRNAs.ASCO-mediatedmodulation ofNSRs results in alternative processing of maturemRNAs, exhibiting events of intron retention,
exon skipping and alternative 5′ or 3′ ends. (v) ENOD40 lncRNA is directly recognized by the nuclear speckle protein RBP1. ENOD40 participates in the
nucleocytoplasmic trafficking of RBP1, inducing its accumulation into cytoplasmic granules, likely modulating RBP1-dependent splicing.
AS during auxin response in roots (39) (Figure 2iv). In
the model legume Medicago truncatula, NSRs closest
homolog, RNA-BINDING PROTEIN 1 (RBP1), is local-
ized in nuclear speckles where many components of the
splicing machinery are hosted in plant cells. Remarkably,
RBP1 interacts with a highly structured lncRNA, EAR-
LYNODULIN40 (ENOD40), which participates in root
symbiotic nodule organogenesis (87). ENOD40 is highly
conserved among legumes and was also found in other
species such as rice (Oryza sativa; (88)). In contrast to the
nuclear localization of Arabidopsis ASCO, ENOD40 was
found both in the nucleus and the cytoplasm, and it is able
to relocalize RBP1 from nuclear speckles into cytoplasmic
granules during nodulation. These observations hint a role
of the lncRNA ENOD40 in nucleocytoplasmic trafficking,
likely modulating RBP1-dependent splicing (89) (Figure
2v).
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ANTISENSE lncRNAs FORMING RNA-RNA DU-
PLEXES
One particular class of lncRNAs is defined by natural an-
tisense transcripts (NATs). NATs are transcribed from the
opposite strand of a protein-coding gene and may or may
not overlap with portions of coding sequences (90). A pio-
neering work in the early 1990s showed that the population
of the oncogene N-myc transcriptional isoforms correlates
with the presence of a NAT encoded across exon 1 in cell
cultures. RNA-RNA duplexes between sense and antisense
transcripts were detected in vivo. Furthermore, duplex for-
mation appeared to occur with only a subset of the multiple
isoforms of the N-myc mRNA. The precise transcriptional
initiation site of the NATwas suggested to play a role in de-
termining this selectivity. It was proposed that duplex for-
mation could modulate pre-mRNA processing by preserv-
ing a population of intron 1-retainedN-mycmRNA (91). It
was recently shown that theN-mycNAT is indeed a protein-
coding RNA, the resultant product of which acts as an
onco-promoting factor in human cancer (92). Soon after the
association ofN-mycNAT with AS, it was demonstrated in
rats that transcription of overlapping antisense transcripts
canmodulate the preference of splicing sites, thus impacting
the population of alternatively spliced variants of a single
locus (93). The erbAα locus encodes two overlapping mR-
NAs, corresponding to the two -thyroid hormone recep-
tor isoforms, TR 1 and TR 2, which arise from alterna-
tive polyadenylation sites of the locus. The erbAα locus also
codes for a thirdmRNA,Rev-erbAα, which is transcribed in
the opposite direction from α1 and α2. Rev-erbAα encodes
another protein belonging to the same steroid/thyroid hor-
mone receptor superfamily. Rev-erbAα overlaps with the 3′
end of α2, but not α1 mRNA. Interestingly, in vitro as-
says demonstrated that the relative abundance of the Rev-
erbAα RNA is capable of blocking the accurate splicing of
erbAα2, likely by RNA-RNA base pairing. This is consis-
tent with the observation that in tissues where Rev-erbAα
mRNA levels are high, the ratio of 2/1 isoforms is rela-
tively low (93,94). More recently, it was shown that TR2
is not expressed in marsupials and that the antisense over-
lap between erbAα and Rev-erbα is unique to eutherian
mammals (95). Although Rev-erbAα and N-myc NAT are
both protein-coding genes, these paradigmatic cases of co-
regulation of overlapping antisense transcripts hinted the
existence of RNAs with dual roles (96), e.g. to code for pro-
teins on one hand, and to exert a role as an RNA molecule
itself, modulating the splicing of a neighboring gene, on the
other.
More recently, the NAT named SAF was linked to pro-
grammed cell death or apoptosis. One major apoptotic
pathway is triggered by the interaction between the cellular
Fas receptor (Fas) and its Fas ligand (FasL). Tumor cells
are frequently resistant to Fas-mediated apoptosis, because
they produce soluble Fas proteins that bind FasL, block-
ing apoptosis. Soluble Fas (sFas) is encoded by the exon
6-skipped alternatively spliced variant of Fas pre-mRNA
(FasΔEx6), which lacks the transmembrane domain. It was
shown that the nuclear-enriched NAT SAF is transcribed
in reverse orientation and from the opposite strand of in-
tron 1 of the Fas locus. An RNA pull-down assay using in
vitro transcribed biotin-labeled SAF served to demonstrate
that it can directly interact with the sense transcript Fas.
Furthermore, an RNAse A protection assay revealed that
the interaction between SAF lncRNA and Fas pre-mRNA
occurs predominantly at exon 5–6 and exon 6–7 junctions.
Strikingly, RNA pull-down followed by mass spectrome-
try revealed that SAF is recognized by the human SF 45
(SPF45), likely facilitating AS and exclusion of exon 6. The
regulation of FasΔEx6 mRNA accumulation leads to the
production of soluble sFas protein, which protects tumor
cells against FasL-induced apoptosis (97) (Figure 3i).
Epithelial–mesenchymal transition (EMT) is first trig-
gered by the expression of the Snail1 transcription factor
in epithelial cells. Snail1 down-regulates specific epithelial
genes, including E-cadherin, and induces the expression of
Zeb1 and two transcriptional regulators, which might ex-
tend the repression of E-cadherin initiated by Snail1. Nor-
mally, the Zeb2 5′-UTR is spliced, conserving a structured
region that inhibits scanning by the ribosomes and therefore
prevents translation of the Zeb2 protein. However, Snail1
promotes the transcription of a NAT encoded in the op-
posite strand of the Zeb2 locus, covering the 5′ splice site
of the Zeb2 5′-UTR. It was proposed that Zeb2 NAT pre-
vents the recognition of the spliceosome by RNA-RNA du-
plex conformation, promoting the inclusion of the intron
present in the Zeb2 5′-UTR. This intron contains an inter-
nal ribosome entry site (IRES) located close to the start of
translation. IRES recognition by the ribosomes promotes
Zeb2 translation, activating EMT (98) (Figure 3ii).
Although the underlying molecular mechanisms remain
largely unknown, another NAT modulating AS also came
to light in relation to brain illness. The Pol III-dependent
lncRNA 17A is transcribed in an antisense way from the in-
tron 3 of the GPR51 gene (G-PROTEIN-COUPLED RE-
CEPTOR 51, coding GABA B2 receptor or GABAB R2)
and is induced by inflammatory molecules. This lncRNA
was found to regulate AS of GPR51 (99). Expression of
17A leads to the production of the GABAB R2 protein
isoform without transduction activity together with a dra-
matic down-regulation of the expression of the canonical
full-length GABAB R2 variant, thus impairing GABAB
signaling. This changing ratio of AS was found to be linked
to Alzheimer’s disease. Also, 17A expression was increased
in patient brains, suggesting an eventual role of this lncRNA
in GPR51 splicing regulation to preserve cerebral function
(99).
LONG NONCODING RNAs AS CHROMATIN REMOD-
ELERS
In the last decade, chromatin structure and histone modifi-
cations have emerged as key regulators of AS. The interac-
tion between histonemodifications, chromatin-binding pro-
teins and SFs possibly constitutes a complex network of
communication between chromatin and RNA (100). Also,
it was demonstrated that the chromatin context influences
RNA polymerase II (Pol II) elongation rate which in turns
affects AS (101–102). This means that epigenetic regula-
tion not only determines which parts of the genome are ex-
pressed, but also how they are spliced (100). Several lncR-
NAs participate in chromatin structure determination and
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Figure 3. Long noncoding RNAs form RNA-RNA duplexes with pre-mRNAs. (i) SAFNAT is encoded in the first intron of the Fas locus. In tumor cells,
SAF is transcribed and it specifically interacts with the exon 6 flanking regions of the pre-mRNA, conforming RNA-RNA duplexes. SAF recruits SPF46,
promoting the exclusion of exon 6. The resulting mRNA encodes for soluble Fas (sFas), which lacks the transmembrane domain. As a result, the presence
of the Fas receptor is reduced in the cell surface whereas sFas sequesters Fas ligand (FasL), rendering cells less sensitive to Fas-mediated apoptosis. (ii)
In epithelial cells, the Zeb2 locus is transcribed into a full 5′UTR-including pre-mRNA. The spliceosome mediates the removal of a 3 kb-long intron in
the 5′UTR. The resulting mRNA contains a stable secondary structure before the AUG, which is capable of blocking translation in the polysomes. On
the other hand, after EMT, the Snail1 transcription factor induces the transcription of Zeb2 NAT in mesenchymal cells. A specific RNA-RNA duplex
encompassing the 5′ splice site of the 5′UTR intron prevents the binding of the spliceosome. Thus, the mRNA contains the full isoform of the 5′UTR,
including an internal ribosome entry site (IRES) proximal to the Zeb2 AUG, favoring translation. Zeb2 transcription factor extends the repression of the
E-cadherin gene initiated by Snail1 during EMT.
dynamics, which may then impact the splicing output, no-
tably by: (i) direct interaction between lncRNAs and DNA
forming heteroduplexes, (ii) recruitment of chromatin mod-
ifiers to specific loci, or (iii) shaping the 3D organization
of chromatin conformation across the cell nucleus. Finally,
we discuss how lncRNA-derived small RNAs control chro-
matin remodeling and may determine AS patterns through
this mechanism.
Splicing regulation by lncRNA-driven DNA–RNA duplexes
Circular RNAs (circRNAs) are covalently-closed circular
molecules of single-stranded RNA, resulting from a non-
canonical splicing event, the so-called back-splicing. This
event consists in the ligation of a downstream splice donor
site reversely with an upstream splice acceptor site from the
pre-mRNA, generating a circular lncRNA molecule. These
circular transcripts are abundant and highly stable, and they
may efficiently compete with the linear pre-mRNA for the
recognition of related splicing protein complexes (103). For
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instance, in flies and humans, the SFMUSCLEBLIND can
strongly and specifically bind to the circRNA derived from
its own locus, called circMbl (104). In human cells, circR-
NAs are dynamically modulated by the SF QKI during hu-
man EMT (105), and it was shown that in human endothe-
lial cells circRNAs occurrence correlates with exon skip-
ping throughout the genome (106). However, the molecular
mechanisms involving circRNAs in animals remain largely
unknown.
It was recently demonstrated in Arabidopsis that a cir-
cRNA can modulate the AS of its own parent gene by di-
rectly interacting with the DNA, forming an RNA-DNA
hybrid known as an R-loop (107). The overexpression of
the circRNA from exon 6 of the SEPALLATA 3 (SEP3)
gene enhances the accumulation of the naturally-occurring
SEP3.3 isoform, which consists of the exon 6-skipped tran-
script.SEP3 belongs to theMADS-box family (named after
the founder members MCM1-AGAMOUS-DEFICIENS-
SRF) of DNA-binding proteins, and it is involved in flower
development inArabidopsis. Themodulation ofSEP3 splic-
ing gives rise to homeotic phenotypes in the flower. Strik-
ingly, the exon 6 circRNA is capable of generating an R-
loop by direct interaction with its own genomic locus, fur-
ther supporting the idea that chromatin conformation plays
a major role in splicing pattern determination (Figure 4i).
Genome-wide characterization of R-loops will be needed
to assess how widely this mechanism occurs throughout the
Arabidopsis genome (108).
Long noncoding RNAs as recruiters of chromatin remodelers
An example of cell-specific AS mediated by lncRNA was
linked to the antisense transcript called asFGFR2. The
lncRNA asFGFR2 is generated from the human FGFR2 lo-
cus and it induces epithelial-specific AS of FGFR2 by pro-
moting chromatin modifications in its own FGFR2 locus. It
was proposed that asFGFR2 recruits chromatin modifiers
specifically to this locus, perhaps via RNA-DNA heterodu-
plexes. Interestingly, chromatin pulldown of a biotinylated
asFGFR2 RNA showed that upon its overexpression, as-
FGFR2 was targeted to the FGFR2 locus precisely around
the differentially spliced intron (109). In epithelial cells,
asFGFR2 was found to recruit chromatin modifiers like
the Polycomb-group proteins and the H3K36 demethy-
lase KDM2a to the FGFR2 locus. As a result, it gener-
ates a chromatin environment that prevents binding of in-
hibitory splicing regulators and favors exon IIIb inclusion
(109). Polycomb-related proteins and KDM2a are differen-
tially recruited along FGFR2 in a cell type–specific manner,
correlating with FGFR2 splicing outcome. The hypothesis
of a direct role of H3K27me3 and the PRC2 component
EZH2 on FGFR2 AS was discarded by expressing EZH2
in cells after knockdown of KDM2a. EZH2 failed to in-
duce exon IIIb inclusion in the absence of KDM2a, indicat-
ing that PRC2 promotes exon IIIb inclusion by maintain-
ing low H3K36me2/3 levels via recruitment of KDM2a.
This epigenetic landscape impairs binding of the chromatin-
splicing adaptor complex MRG15–PTB, which normally
inhibits the inclusion of exon IIIb. The antagonistic effect of
H3K36me3 and H3K27me3 on FGFR2 splicing points to a
lncRNA-mediated cross-talk between these histone modifi-
cations (109) (Figure 4ii).
Also, the mentioned splicing-related lncRNA MALAT1
was identified as a key regulator of Polycomb 2 protein (Pc2)
methylation status, impacting chromatin conformation
(110). It was reported that the methylation/demethylation
of Pc2 determines the relocation of growth control genes
between Polycomb bodies (PcGs) and interchromatin
granules (ICGs). This behavior is ruled by the binding
of methylated and unmethylated Pc2 to two lncRNAs,
TUG1 and MALAT1, located in PcGs and ICGs, re-
spectively. TUG1- and MALAT1-associated proteins were
identified by pull-down using biotinylated RNAs fol-
lowed by mass spectrometric analysis. This approach re-
vealed thatMALAT1 RNA bound not only to pre-mRNA
SFs, but also to transcriptional co-activators and histone
methyltransferases/demethylases associated with active hi-
stone marks; whereas TUG1 RNA also specifically binds
to a number of proteins involved in transcriptional repres-
sion, including histone methyltransferases/demethylases
and chromatin modifiers. It transpired that these lncR-
NAs mediate the assembly of multiple co-repressors/co-
activators, and can alter the histone marks read by Pc2
in vitro. Additionally, binding of MALAT1 to unmethy-
lated Pc2 promotes SUMOylation of the transcription fac-
tor E2F1, leading to activation of the growth control gene
program. Therefore,MALAT1 also participates in themod-
ulation of the chromatin remodeling environment by selec-
tively interacting with chromatin modifier proteins (110).
Although there is no evidence of any direct link between
MALAT1- or TUG1-mediated chromatin modulation and
splicing, future studies will be needed to determine if the
chromatin-related function of these lncRNAs may conse-
quently affect AS of target genes.
Long noncoding RNAs shape the three-dimensional genome
organization
The molecular pathway linking the actions of subnuclear
structure-specific lncRNAs, such as TUG1 and MALAT1,
and non-histone protein methylation to spatial relocation
of transcription units in the nucleus, hints the role of lncR-
NAs in the dynamic 3D configuration of the genome in the
cell nucleus.Nuclear spatial organization and chromatin 3D
modulation by lncRNAs (37,111–116) as well as AS modu-
lation by chromatin modifications (for review see (100,117))
have long been described in mammalian cells as well as in
plants.
The splicing-related lncRNAs NEAT1 and MALAT1
were used as baits to map their binding sites across the
human genome (118) by Capture Hybridization Analysis
of RNA Targets (CHART; (119)). Strikingly, NEAT1 and
MALAT1 localize to hundreds of loci in human cells, pri-
marily on actively transcribed genes. Many of these loci
were co-enriched in NEAT1 and MALAT1 CHARTs, al-
though displaying distinct gene body binding patterns, sug-
gesting independent but complementary functions for both
lncRNAs. CHART followed bymass spectrometry was also
performed to identify NEAT1 and MALAT1 interactors,
revealing common nuclear speckle and paraspeckle com-
ponents. The elucidation of ribonucleoprotein complexes
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Figure 4. Long noncoding RNAs as chromatin remodelers. (i) The exon 6 of the SEP3 gene is transcribed and back-spliced into a circular RNA. The SEP3
circRNA directly interacts with its parent gene DNA, conforming a DNA–RNA duplex known as an R-loop and promoting the exon 6 skipping, thus the
accumulation of the SEP3.3 mRNA isoform. (ii) The antisense transcript of the FGFR2 gene, called asFGFR2 (in red), recruits the PRC2 proteins EZH2
and SUZ12 to its parent locus, triggering the deposition of H3K27me3 and the recruitment of the H3K36 demethylase KDM2a. This complex enhances
the deposition of H3K36me3 and impairs the binding of the chromatin-splicing adaptor complex MRG15–PTB to the exon IIIb, which is finally included
in the mature mRNA (in green). (iii)NEAT1 andMALAT1 bind to common and distinct actively transcribed loci across the genome. Their binding on the
gene body is different between them, e.g.NEAT1 binding peaks at the transcription start site as well as the end of the locus, whereasMALAT1 preferentially
binds only at the end of the gene. It was proposed thatMALAT1 andNEAT1 promote the formation of splicing-related nuclear speckles and paraspeckles,
respectively, around its site of transcription of targeted loci.
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further supports complementary binding and functions ex-
erted by both lncRNAs. The dynamic interactions between
nuclear speckles and gene bodies indicate that speckles may
serve as a concentrated reservoir of SFs that shuttle to
transcribed genes (120,121). Considering that speckles fre-
quently localize within the vicinity of actively transcribed
genes undergoing co-transcriptional splicing (122,123), it
was proposed that nuclear bodies may be organized around
genes regulated by NEAT1 and MALAT1 (118). The pre-
vious elucidation of the 3D chromatin organization of hu-
man cells indicated that theMALAT1 andNEAT1 genomic
loci are located in close proximity in the nucleus (124). Ac-
cording to this model, NEAT1 and MALAT1 could shape
the structure of nuclear bodies at highly transcribed loci, as
NEAT1 also participates in the organization of paraspeckle
formation around its site of transcription (111,112) (Fig-
ure 4.iii). Alternatively, NEAT1 and MALAT1 may serve
as scaffolds, such as Xist or HOTAIR (119,125,126), bring-
ing proteins that also interact with components of nu-
clear speckles and paraspeckles, together with RNA and/or
DNA binding proteins. This model considers the action of
lncRNAs as molecular bridges between specific chromoso-
mal locations and nuclear speckles and paraspeckles (118).
Small RNAs in the interplay between splicing and chromatin
compaction
Small ncRNAs (smRNAs) derived from lncRNA precur-
sors act as small molecules of <50 nt. Since the discov-
ery of RNA-mediated gene silencing by small interfering
RNAs (siRNAs) (127,128), other classes of small RNAs
with multiple functions have been identified, such as mi-
croRNAs (miRNAs) (129), small RNA fragments derived
from tRNAs (tsRNAs) and small RNA fragments derived
from small nucleolar (sno)RNAs (sdRNAs, sno-derived
RNAs) (130,131). It has been demonstrated that they reg-
ulate gene expression by multiple mechanisms, such as tar-
geting mRNA cleavage, translational or transcriptional re-
pression, decoys of mRNAs or through the generation of
other secondary smRNAs (132–134) and protein sequester-
ing or titration (135). During transcriptional gene silenc-
ing, siRNAs trigger heterochromatin formation at DNA
target sequences. Various plants and yeast studies have re-
ported the relationship between splicing and silencing me-
diated by smRNA-directed heterochromatin formation. In
particular, several mutants in SFs-encoding genes turned
out to be also impaired in the silencing of certain genes
(136–140). In Schizosaccharomyces pombe, mutation in any
of the two SF-encoding genesCwf10 or Prp39was found to
reduce centromeric siRNAs accumulation and to increase
repeated transcripts like dg and dh (136). In the same way,
mutation of a single nucleotide in the U4 snRNA gene im-
pairs centromere silencing (137). In both cases, some SFs
were found to facilitate siRNA production tomodulate het-
erochromatin formation and induce centromere silencing.
Similarly, in Arabidopsis the SF SR45 was found to be in-
volved in de novo methylation by the RNA-directed DNA
methylation (RdDM) pathway. In fact, the sr45mutant de-
creased siRNAs and DNA methylation in transgenic FWA
(FLOWERINGWAGENINGEN) in company with the as-
sociated late flowering phenotype (138). Another example
is the Arabidopsis SMALL NUCLEAR RIBONUCLEO-
PROTEIN D1 (SmD1) which was proposed to play a role
in plants during splicing since a mutant exhibits altered
AS of certain genes. This protein was also found to fa-
cilitate post-transcriptional gene silencing (PTGS) by pro-
tecting transgene aberrant RNAs from degradation by the
NMD pathway. As a result, enough template is provided
for siRNAs production establishing a link between aberrant
RNA and AS (141). Apart from these examples of interac-
tion between the splicing machinery and smRNA-directed
heterochromatin formation, new studies also pointed out
a link involving smRNAs in the regulation of AS through
chromatin remodelling, a process that can be regulated by
smRNAs. It was shown in humans, flies and worms that
nucleosome density is higher over exons than introns sug-
gesting that nucleosome positioning defines exons at the
chromatin level (142–146). The chromatin context influ-
ences RNA polymerase II (Pol II) elongation rate which in
turns affects AS (100–102). Rapid transcription favors exon
skipping whereas slower transcription stimulates the use of
weak splice sites of variant exons promoting the intron in-
clusion process or other alternative sites for splicing reac-
tions (146,147). For instance, the FIBRONECTIN 1 gene
(FN1) produces different protein isoforms through AS of
exon extra domain I (EDI). In hepatoma and HeLa cells,
it was described that exogenous applied siRNAs targeting
gene sequences located close to EDI alternative exon lead
to a heterochromatic state in the site which affects Pol II
elongation efficiency and mediates AS of EDI (148). This
regulation was found to be dependent on ARGONAUTE 1
(AGO1), which is a crucial actor in RNA silencing, bind-
ing siRNAs to recognize their target RNAs. Another ex-
ample of AS mediated by siRNAs is the inclusion of exon
18 of the NEURAL CELL ADHESION MOLECULE
(NCAM) gene which is regulated by heterochromatinmarks
after differentiation of mouse N2a neural cells. This pro-
cess could also be induced by exogenous application of
exon-targeted siRNAs in undifferentiated N2a cells (149).
These examples suggest that siRNAs could regulate AS
through the modulation of heterochromatin in specific sites
in order to fine-tune the Pol II elongation rate. Besides
the mechanistic implications of using exogenous applied
siRNAs to specific alternative exons, a genome-wide ap-
proach hinted the potential relevance of this mechanism
in physiological conditions (150). Remarkably, purification
of AGO1 and AGO2 chromatin associated complexes re-
vealed their interaction with SFs. Furthermore, approxi-
mately one-third of smRNAs loaded in these AGO1 and
AGO2 complexes align specifically with 3′ ends of introns,
the intron–exon junctions (150). These observations suggest
that these intron-related smRNAs and the RNAi protein
machinery could have a function in AS regulation. More-
over, genome-wide exon arrays on embryonic fibroblasts of
Ago2- or Dicer-null mice showed that they have similar al-
tered AS events (150). In this work, the CD44 gene was
taken as a model to characterise the underlying mechanism
because several of its alternative exons can be highly in-
cluded by a phorbol-12-myristate 13-acetate (PMA) treat-
ment (150,151). In mammalian cells treated with PMA,
smRNAs recruited AGO1 and AGO2 to the transcribed
regions of CD44 in a Dicer- and HP1 (HETEROCHRO-
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MATIN PROTEIN 1)-dependent manner, which increased
local H3K9me3 levels at the region corresponding to the
variable exons. Subsequently, the AGO proteins facilitate
spliceosome recruitment and modulation of Pol II proces-
sivity in order to shape CD44 AS (150), further suggesting
an involvement of smRNAs in splicing regulation. Hete-
rochromatin regulation by smRNAs is widely found in dif-
ferent organisms among yeast, plants andmammals. There-
fore, it is possible that the interplay between splicing and
smRNAs/heterochromatin pathway is a widespread mech-
anism in eukaryotes to rapidly regulate splicing and AS
rates of specific genes throughout growth and differentia-
tion.
CONCLUSIONS
Generally, regulation of AS by lncRNAs seems to be a com-
mon emerging event in many species although the underly-
ing mechanisms differ among them. In this review, we have
classified and sub-classified splicing-related lncRNAs char-
acterized from different species and kingdoms, according to
the commonalities and singularities of their interactionwith
SFs, their direct association with pre-mRNAs, their roles in
nuclear localization processes or their impact on chromatin
conformation. The involvement of lncRNAs in AS regula-
tion seems to be critical under specific conditions, as im-
pairing the production of lncRNAs could lead to diseases
in mammals or developmental disorders in plants.
LncRNA-derived small RNAs have also been described
here, as their action in the modulation of the chromatin
context in the gene body in order to modify Pol II elon-
gation rate, may privilege inclusion or exclusion of specific
exon/introns. The identification of certain proteins involved
in both, splicing and siRNA production, supports the im-
plication of smRNAs in the regulation of AS.
Some lncRNAs and their mode of action are conserved
in closely related species, as it is the case of MALAT1.
Nevertheless, the sequence of the majority of lncRNAs are
not conserved across species and common roles of differ-
ent lncRNAs in AS regulation suggests that structural pat-
terns may be conserved for proper recognition by SFs. Fur-
ther studies on the structure of lncRNAs interacting with
SFs across species should shed light on the evolution of
these mechanisms. Novel methods developed in the last
few years will certainly continue to cope with this chal-
lenge. For instance, Cross-Linking and ImmunoPrecipita-
tion (CLIP) assays are used to identify specific RNA se-
quences bound by protein partners (152,153). Also, RNA
Hybrid and Individual-nucleotide resolution UV Cross-
Linking and ImmunoPrecipitation (hiCLIP) allows us to
identify RNA duplexes, particular RNA intramolecular
structures or intermolecular interactions at nucleotide res-
olution level, bound by specific RNA-associated proteins
(154). It is worth considering the differential accumulation
and sub-cellular localization of lncRNAs in response to ex-
ternal or intrinsic stimuli. This suggests that, for a given or-
ganism, different lncRNAs with similar structures may be
recognized by common proteins and exert the same role in
alternative developmental contexts.
The link between ncRNAs and diseases clearly highlights
the interest in further studies about the so-called dark mat-
ter of the genome. A deeper knowledge about lncRNAs ac-
tivity will help us to detect and hopefully treat a wider range
of diseases. For instance, the antisense transcript of the EPI-
DERMAL GROWTH FACTOR RECEPTOR (EGFR)
coding locus, the NAT EGFR-AS1, was recently shown to
modulate the EGFR isoforms abundance. Targeting EGFR
is a validated approach in the treatment of squamous-cell
cancers (SCCs). Notably, a silent punctual mutation im-
pacts the accumulation of EGFR-AS1, what was proposed
as a predictive biomarker for SCCs. However, the molecular
mechanisms governingEGFR splicing regulation byAGFR-
AS1 remain unknown (155).
In plant biology, the identification of differentially ex-
pressed lncRNAs in crops, including variation in different
ecotypes, may help us decipher how different varieties can
adapt to changing environments. A more comprehensive
knowledge about the plasticity of plant genomes and the
impact of lncRNA in the modulation of the protein-coding
genome will certainly allow us to develop novel strategies
for sustainable agriculture.
As the noncoding transcriptome, mainly composed of in-
trons and ncRNAs, is the major component of the eukary-
otic genome, there may be a large reservoir of mechanisms
through which ncRNAs can interact with the splicing ma-
chinery tomodulate and boost the proteome plasticity, con-
tributing to the expansion of diversity in life. Mechanistic
insight into how long and small noncoding RNAs are re-
cruited and fine-tune AS may open large perspectives as
novel tools in gene therapy for several diseases including
cancer, as well as in biotechnological applications in agri-
culture and human health.
FUNDING
Funding for open access charge: grant from ANPCyT, Ar-
gentina, PICT 2016-0289.
Conflict of interest statement.None declared.
REFERENCES
1. Marquez,Y., Brown,J.W.S., Simpson,C., Barta,A. and Kalyna,M.
(2012) Transcriptome survey reveals increased complexity of the
alternative splicing landscape in Arabidopsis. Genome Res., 22,
1184–1195.
2. Gerstein,M.B., Rozowsky,J., Yan,K.-K., Wang,D., Cheng,C.,
Brown,J.B., Davis,C.A., Hillier,L., Sisu,C., Li,J.J. et al. (2014)
Comparative analysis of the transcriptome across distant species.
Nature, 512, 445–448.
3. Pan,Q., Shai,O., Lee,L.J., Frey,B.J. and Blencowe,B.J. (2008) Deep
surveying of alternative splicing complexity in the human
transcriptome by high-throughput sequencing. Nat. Genet., 40,
1413–1415.
4. Wang,E.T., Sandberg,R., Luo,S., Khrebtukova,I., Zhang,L.,
Mayr,C., Kingsmore,S.F., Schroth,G.P. and Burge,C.B. (2008)
Alternative isoform regulation in human tissue transcriptomes.
Nature, 456, 470–476.
5. Syed,N.H., Kalyna,M., Marquez,Y., Barta,A. and Brown,J.W.S.
(2012) Alternative splicing in plants–coming of age. Trends Plant
Sci., 17, 616–623.
6. Djebali,S., Davis,C.A., Merkel,A. and Gingeras,T.R. (2012)
Landscape of transcription in human cells. Nature, 489, 101–108.
7. Boon,K.-L., Grainger,R.J., Ehsani,P., Barrass,J.D.,
Auchynnikava,T., Inglehearn,C.F. and Beggs,J.D. (2007) prp8
mutations that cause human retinitis pigmentosa lead to a U5
snRNP maturation defect in yeast. Nat. Struct. Mol. Biol., 14,
1077–1083.
Downloaded from https://academic.oup.com/nar/advance-article-abstract/doi/10.1093/nar/gky095/4841659
by guest
on 08 February 2018
Nucleic Acids Research, 2018 13
8. Tanackovic,G., Ransijn,A., Thibault,P., Elela,S.A., Klinck,R.,
Berson,E.L., Chabot,B. and Rivolta,C. (2011) PRPF mutations are
associated with generalized defects in spliceosome formation and
pre-mRNA splicing in patients with retinitis pigmentosa.Hum. Mol.
Genet., 20, 2116–2130.
9. Yoshida,K., Sanada,M., Shiraishi,Y., Nowak,D., Nagata,Y.,
Yamamoto,R., Sato,Y., Sato-Otsubo,A., Kon,A., Nagasaki,M. et al.
(2011) Frequent pathway mutations of splicing machinery in
myelodysplasia. Nature, 478, 64–69.
10. Scotti,M.M. and Swanson,M.S. (2015) RNA mis-splicing in disease.
Nat. Rev. Genet., 17, 19–32.
11. Yan,K., Liu,P., Wu,C.-A., Yang,G.-D., Xu,R., Guo,Q.-H.,
Huang,J.-G. and Zheng,C.-C. (2012) Stress-induced alternative
splicing provides a mechanism for the regulation of microRNA
processing in Arabidopsis thaliana.Mol. Cell, 48, 521–531.
12. Reddy,A.S.N., Marquez,Y., Kalyna,M. and Barta,A. (2013)
Complexity of the alternative splicing landscape in plants. Plant
Cell, 25, 3657–3683.
13. Ding,F., Cui,P., Wang,Z., Zhang,S., Ali,S. and Xiong,L. (2014)
Genome-wide analysis of alternative splicing of pre-mRNA under
salt stress in Arabidopsis. BMC Genomics, 15, 1–14.
14. Zhan,X., Qian,B., Cao,F., Wu,W., Yang,L., Guan,Q., Gu,X.,
Wang,P., Okusolubo,T.A., Dunn,S.L. et al. (2015) An Arabidopsis
PWI and RRMmotif-containing protein is critical for pre-mRNA
splicing and ABA responses. Nat. Commun., 6, 8139.
15. Palusa,S.G. and Reddy,A.S.N. (2015) Differential recruitment of
splice variants from SR Pre-mRNAs to polysomes during
development and in response to stresses. Plant Cell Physiol., 56,
421–427.
16. Rauch,H.B., Patrick,T.L., Klusman,K.M., Battistuzzi,F.U., Mei,W.,
Brendel,V.P. and Lal,S.K. (2013) Discovery and Expression Analysis
of Alternative Splicing Events Conserved among Plant SR Proteins.
Mol. Biol. Evol., 31, 605–613.
17. Palusa,S.G., Ali,G.S. and Reddy,A.S.N. (2007) Alternative splicing
of pre-mRNAs of Arabidopsis serine / arginine-rich proteins:
regulation by hormones and stresses. Plant J., 49, 1091–1107.
18. Seo,P.J., Park,M.-J. and Park,C.-M. (2013) Alternative splicing of
transcription factors in plant responses to low temperature stress:
mechanisms and functions. Planta, 237, 1415–1424.
19. Severing,E.I., Dijk,A.D.J. Van, Morabito,G. and Busscher-lange,J.
(2012) Predicting the Impact of Alternative Splicing on Plant
MADS Domain Protein Function. PLoS One, 7, e30524.
20. Lareau,L.F. and Brenner,S.E. (2015) Regulation of splicing factors
by alternative splicing and NMD is conserved between kingdoms yet
evolutionarily flexible.Mol. Biol. Evol., 32, 1072–1079.
21. Reddy,A.S.N., Rogers,M.F., Richardson,D.N., Hamilton,M. and
Ben-Hur,A. (2012) Deciphering the Plant Splicing Code:
Experimental and Computational Approaches for Predicting
Alternative Splicing and Splicing Regulatory Elements. Front. Plant
Sci., 3, 18.
22. Tran,V.D.T., Souiai,O., Romero-Barrios,N., Crespi,M. and
Gautheret,D. (2016) Detection of generic differential RNA
processing events from RNA-seq data. RNA Biol., 13, 59–67.
23. Matlin,A.J., Clark,F. and Smith,C.W.J. (2005) Understanding
alternative splicing: towards a cellular code. Nat. Rev. Mol. Cell
Biol., 6, 386–398.
24. Blencowe,B.J. (2006) Alternative splicing: new insights from global
analyses. Cell, 126, 37–47.
25. Wang,G.-S. and Cooper,T.A. (2007) Splicing in disease: disruption
of the splicing code and the decoding machinery. Nat. Rev. Genet.,
8, 749–761.
26. Faial,T. (2015) RNA splicing in common disease.Nat Genet, 47, 105.
27. Filichkin,S.A., Priest,H.D., Givan,S.A., Shen,R., Bryant,D.W.,
Fox,S.E., Wong,W. and Mockler,T.C. (2010) Genome-wide mapping
of alternative splicing in Arabidopsis thaliana. Genome Res., 20,
45–58.
28. Tanabe,N., Yoshimura,K., Kimura,A. and Yabuta,Y. (2007)
Differential Expression of Alternatively Spliced mRNAs of
Arabidopsis SR Protein Homologs, atSR30 and atSR45a, in
Response to Environmental Stress. Plant Cell Physiol., 48,
1036–1049.
29. Wang,K.C. and Chang,H.Y. (2016) Molecular mechanisms of long
noncoding RNAs.Mol. Cell, 43, 904–914.
30. Guttman,M. and Rinn,J.L. (2012) Modular regulatory principles of
large non-coding RNAs. Nature, 482, 339–346.
31. Moran,V.A., Perera,R.J. and Khalil,A.M. (2012) Emerging
functional and mechanistic paradigms of mammalian long
non-coding RNAs. 40, 6391–6400.
32. Matera,A.G. and Wang,Z. (2014) A day in the life of the
spliceosome. Nat. Rev. Mol. Cell Biol., 15, 108–121.
33. Rappsilber,J., Ryder,U., Lamond,A.I. and Mann,M. (2002)
Large-scale proteomic analysis of the human spliceosome. Genome
Res., 12, 1231–1245.
34. Herold,N., Will,C.L., Wolf,E., Kastner,B., Urlaub,H. and Lu,R.
(2009) Conservation of the protein composition and electron
microscopy structure of Drosophila melanogaster and human
spliceosomal complexes.Mol. Cell Biol., 29, 281–301.
35. Wang,B. and Brendel,V. (2004) The ASRG database: identification
and survey of Arabidopsis thaliana genes involved in pre-mRNA
splicing. Genome Biol., 5, R102.
36. Zhang,Y., Zhang,X.-O., Chen,T., Xiang,J.-F., Yin,Q.-F., Xing,Y.-H.,
Zhu,S., Yang,L. and Chen,L.-L. (2013) Circular intronic long
noncoding RNAs.Mol. Cell, 51, 792–806.
37. Ariel,F., Jegu,T., Latrasse,D., Romero-Barrios,N., Christ,A.,
Benhamed,M. and Crespi,M. (2014) Noncoding transcription by
alternative rna polymerases dynamically regulates an auxin-driven
chromatin loop.Mol. Cell, 55, 383–396.
38. Ariel,F., Romero-Barrios,N., Jegu,T., Benhamed,M. and Crespi,M.
(2015) Battles and hijacks: noncoding transcription in plants. Trends
Plant Sci., 20, 362–371.
39. Bardou,F., Ariel,F., Simpson,C.G., Romero-Barrios,N., Laporte,P.,
Balzergue,S., Brown,J.W.S. and Crespi,M. (2014) Long noncoding
RNA modulates alternative splicing regulators in Arabidopsis. Dev.
Cell, 30, 166–176.
40. Song,P., Ye,L.-F., Zhang,C., Peng,T. and Zhou,X.-H. (2016) Long
non-coding RNA XIST exerts oncogenic functions in human
nasopharyngeal carcinoma by targeting miR-34a-5p. Gene, 592,
8–14.
41. Hutchinson,J.N., Ensminger,A.W., Clemson,C.M., Lynch,C.R.,
Lawrence,J.B. and Chess,A. (2007) A screen for nuclear transcripts
identifies two linked noncoding RNAs associated with SC35 splicing
domains. BMC Genomics, 8, 39.
42. Long,J.C. and Caceres,J.F. (2009) The SR protein family of splicing
factors: master regulators of gene expression. Biochem. J., 417,
15–27.
43. Cao,W., Jamison,S.F. and Garcia-Blanco,M.A. (1997) Both
phosphorylation and dephosphorylation of ASF/SF2 are required
for pre-mRNA splicing in vitro. RNA, 3, 1456–1467.
44. Xiao,S.H. and Manley,J.L. (1997) Phosphorylation of the ASF/SF2
RS domain affects both protein-protein and protein-RNA
interactions and is necessary for splicing. Genes Dev., 11, 334–344.
45. Xiao,S.H. and Manley,J.L. (1998)
Phosphorylation-dephosphorylation differentially affects activities
of splicing factor ASF/SF2. EMBO J., 17, 6359–6367.
46. Ca´ceres,J.F., Misteli,T., Screaton,G.R., Spector,D.L. and
Krainer,A.R. (1997) Role of the modular domains of SR proteins in
subnuclear localization and alternative splicing specificity. J. Cell
Biol., 138, 225–238.
47. Misteli,T., Ca´ceres,J.F., Clement,J.Q., Krainer,A.R.,
Wilkinson,M.F. and Spector,D.L. (1998) Serine phosphorylation of
SR proteins is required for their recruitment to sites of transcription
in vivo. J. Cell Biol., 143, 297–307.
48. Jiang,K., Patel,N.A., Watson,J.E., Apostolatos,H., Kleiman,E.,
Hanson,O., Hagiwara,M. and Cooper,D.R. (2009) Akt2 regulation
of Cdc2-like kinases (Clk/Sty), serine/arginine-rich (SR) protein
phosphorylation, and insulin-induced alternative splicing of
PKCJII messenger ribonucleic acid. Endocrinology, 150,
2087–2097.
49. Cooper,D.R., Carter,G., Li,P., Patel,R., Watson,J.E. and Patel,N.A.
(2014) Long non-coding RNA NEAT1 associates with SRp40 to
temporally regulate PPAR2 splicing during Adipogenesis in
3T3-L1 cells. Genes (Basel)., 5, 1050–1063.
50. Wang,X., Sehgal,L., Jain,N., Khashab,T., Mathur,R. and
Samaniego,F. (2016) LncRNAMALAT1 promotes development of
mantle cell lymphoma by associating with EZH2. J. Transl. Med.,
14, 346.
Downloaded from https://academic.oup.com/nar/advance-article-abstract/doi/10.1093/nar/gky095/4841659
by guest
on 08 February 2018
14 Nucleic Acids Research, 2018
51. Malakar,P., Shilo,A., Mogilavsky,A., Stein,I., Pikarsky,E., Nevo,Y.,
Benyamini,H., Elgavish,S., Zong,X., Prasanth,K. V et al. (2016)
Long noncoding RNAMALAT1 promotes hepatocellular
carcinoma development by SRSF1 up-regulation and mTOR
activation. Cancer Res., 77, 1155–1167.
52. Li,R.-Q., Ren,Y., Liu,W., Pan,W., Xu,F.-J. and Yang,M. (2017)
MicroRNA-mediated silence of onco-lncRNAMALAT1 in
different ESCC cells via ligand-functionalized hydroxyl-rich
nanovectors. Nanoscale, 9, 2521–2530.
53. Chen,W., Xu,X., Li,J., Kong,K., Li,H. and Chen,C. (2017)
MALAT1 is a prognostic factor in glioblastoma multiforme and
induces chemoresistance to temozolomide through suppressing
miR-203 and promoting thymidylate synthase expression.
Oncotarget, 8, 22783–22799.
54. Li,Z., Zhou,Y., Tu,B., Bu,Y., Liu,A. and Xie,C. (2016) Long
noncoding RNAMALAT1 affects the efficacy of radiotherapy for
esophageal squamous cell carcinoma by regulating Cks1 expression.
J. Oral Pathol. Med., 46, 583–590.
55. Tripathi,V., Ellis,J.D., Shen,Z., Song,D.Y., Pan,Q., Watt,A.T.,
Freier,S.M., Bennett,C.F., Sharma,A., Bubulya,P.A. et al. (2010)
The nuclear-retained noncoding RNAMALAT1 regulates
alternative splicing by modulating SR splicing factor
phosphorylation.Mol. Cell, 39, 925–938.
56. Stamm,S. (2008) Regulation of alternative splicing by reversible
protein phosphorylation. J. Biol. Chem., 283, 1223–1227.
57. Huang,Y., Yario,T.A. and Steitz,J.A. (2004) A molecular link
between SR protein dephosphorylation and mRNA export. Proc.
Natl. Acad. Sci. U.S.A., 101, 9666–9670.
58. Sanford,J.R., Ellis,J.D., Cazalla,D. and Ca´ceres,J.F. (2005)
Reversible phosphorylation differentially affects nuclear and
cytoplasmic functions of splicing factor 2/alternative splicing factor.
Proc. Natl. Acad. Sci. U.S.A., 102, 15042–15047.
59. Shi,Y. and Manley,J.L. (2007) A complex signaling pathway
regulates SRp38 phosphorylation and pre-mRNA splicing in
response to heat shock.Mol. Cell, 28, 79–90.
60. Zhong,X.Y., Ding,J.H., Adams,J.A., Ghosh,G. and Fu,X.D. (2009)
Regulation of SR protein phosphorylation and alternative splicing
by modulating kinetic interactions of SRPK1 with molecular
chaperones. Genes Dev., 23, 482–495.
61. Patton,J.G., Mayer,S.A., Tempst,P. and Nadal-Ginard,B. (1991)
Characterization and molecular cloning of polypymiridine
tract-binding protein: a component of a complex necessary for
pre-mRNA splicing. Genes Dev., 5, 1237–1251.
62. He,X., Pool,M., Darcy,K.M., Lim,S.B., Auersperg,N., Coon,J.S.
and Beck,W.T. (2007) Knockdown of polypyrimidine tract-binding
protein suppresses ovarian tumor cell growth and invasiveness in
vitro. Oncogene, 26, 4961–4968.
63. Patton,J.G., Porto,E.B., Galceran,J., Paul,T. and Nadal-ginard,B.
(1993) Cloning and characterization of PSF, a novel pre-mRNA
splicing factor. Genes Dev., 7, 393–406.
64. Gozani,O., Patton,J.G. and Reed,R. (1994) A novel set of
spliceosome-associated proteins and the essential splicing factor
PSF bind stably to pre-mRNA prior to catalytic step II of the
splicing reaction. EMBO J., 13, 3356–3367.
65. Meissner,M., Dechat,T., Gerner,C., Grimm,R., Foisner,R. and
Sauermann,G. (2000) Differential nuclear localization and nuclear
matrix association of the splicing factors PSF and PTB. J. Cell.
Biochem., 76, 559–566.
66. Ji,Q., Zhang,L., Liu,X., Zhou,L., Wang,W., Han,Z., Sui,H.,
Tang,Y., Wang,Y., Liu,N. et al. (2014) Long non-coding RNA
MALAT1 promotes tumour growth and metastasis in colorectal
cancer through binding to SFPQ and releasing oncogene PTBP2
from SFPQ / PTBP2 complex. Br. J. Cancer, 111, 736–748.
67. Wang,G., Cui,Y., Zhang,G., Garen,A. and Song,X. (2009)
Regulation of proto-oncogene transcription, cell proliferation, and
tumorigenesis in mice by PSF protein and a VL30 noncoding RNA.
Proc. Natl. Acad. Sci. U.S.A., 106, 16794–16798.
68. Li,L., Feng,T., Lian,Y., Zhang,G., Garen,A. and Song,X. (2009)
Role of human noncoding RNAs in the control of tumorigenesis.
Proc. Natl. Acad. Sci. U.S.A., 106, 12956–12961.
69. Kong,J., Sun,W., Li,C., Wan,L., Wang,S., Wu,Y., Xu,E., Zhang,H.
and Lai,M. (2016) Long non-coding RNA LINC01133 inhibits
epithelial-mesenchymal transition and metastasis in colorectal
cancer by interacting with SRSF6. Cancer Lett., 380, 476–484.
70. Zang,C., Nie,F., Wang,Q., Sun,M., Li,W., He,J., Zhang,M. and
Lu,K. (2016) Long non-coding RNA LINC01133 represses KLF2,
P21 and E-cadherin transcription through binding with EZH2,
LSD1 in non small cell lung cancer. Oncotarget, 7, 11696–11707.
71. Barry,G., Briggs,J., Vanichkina,D., Poth,E., Beveridge,N., Ratnu,V.,
Nayler,S., Nones,K., Hu,J., Bredy,T. et al. (2013) The long
non-coding RNA Gomafu is acutely regulated in response to
neuronal activation and involved in schizophrenia-associated
alternative splicing.Mol. Psychiatry, 19, 486–494.
72. Rapicavoli,N. a, Poth,E.M. and Blackshaw,S. (2010) The long
noncoding RNA RNCR2 directs mouse retinal cell specification.
BMC Dev. Biol., 10, 49.
73. Rapicavoli,N.A. and Blackshaw,S. (2009) New meaning in the
message: Noncoding RNAs and their role in retinal development.
Dev. Dyn., 238, 2103–2114.
74. Mercer,T.R., Qureshi,I.A., Gokhan,S., Dinger,M.E., Li,G.,
Mattick,J.S. and Mehler,M.F. (2010) Long noncoding RNAs in
neuronal-glial fate specification and oligodendrocyte lineage
maturation. BMC Neurosci., 11, 14.
75. Mercer,T.R., Dinger,M.E., Sunkin,S.M., Mehler,M.F. and
Mattick,J.S. (2007) Specific expression of long noncoding RNAs in
the mouse brain. Proc. Natl. Acad. Sci. U.S.A., 105, 716–721.
76. Sone,M., Hayashi,T., Tarui,H., Agata,K., Takeichi,M. and
Nakagawa,S. (2007) The mRNA-like noncoding RNA Gomafu
constitutes a novel nuclear domain in a subset of neurons. J. Cell
Sci., 120, 2498–2506.
77. Tsuiji,H., Yoshimoto,R., Hasegawa,Y., Furuno,M., Yoshida,M. and
Nakagawa,S. (2011) Competition between a noncoding exon and
introns: Gomafu contains tandem UACUAAC repeats and
associates with splicing factor-1. Genes Cells, 16, 479–490.
78. Ladd,A.N. (2013) CUG-BP, Elav-like family (CELF)-mediated
alternative splicing regulation in the brain during health and disease.
Mol. Cell Neurosci., 29, 456–464.
79. Ishizuka,A., Hasegawa,Y., Ishida,K., Yanaka,K. and Nakagawa,S.
(2014) Formation of nuclear bodies by the lncRNA
Gomafu-associating proteins Celf3 and SF1. Genes Cells, 19,
704–721.
80. van Dijk,M., Visser,A., Buabeng,K.M.L., Poutsma,A., van der
Schors,R.C. and Oudejans,C.B.M. (2015) Mutations within the
LINC-HELLP non-coding RNA differentially bind ribosomal and
RNA splicing complexes and negatively affect trophoblast
differentiation. Hum. Mol. Genet., 24, 5475–5485.
81. Boisvert,F.M., Van Koningsbruggen,S., Navascue´s,J. and
Lamond,A.I. (2007) The multifunctional nucleolus. Nat. Rev. Mol.
Cell Biol., 8, 574–585.
82. Kiss,T., Agris,P., Bachellerie,J., Michot,B., Nicoloso,M.,
Balakin,A., Ni,J., Fournier,M., Balakin,A., Smith,L. et al. (2001)
Small nucleolar RNA-guided post-transcriptional modification of
cellular RNAs. EMBO J., 20, 3617–3622.
83. Matera,A.G., Terns,R.M. and Terns,M.P. (2007) Non-coding
RNAs: Lessons from the small nuclear and small nucleolar RNAs.
Nat. Rev. Mol. Cell Biol., 8, 209–220.
84. Yin,Q.F., Yang,L., Zhang,Y., Xiang,J.F., Wu,Y.W., Carmichael,G.G.
and Chen,L.L. (2012) Long Noncoding RNAs with snoRNA Ends.
Mol. Cell, 48, 219–230.
85. Kishore,S. and Stamm,S. (2006) The snoRNA HBII-52 regulates
alternative splicing of the serotonin receptor 2C. Science, 311,
230–232.
86. Wu,H., Yin,Q.F., Luo,Z., Yao,R.W., Zheng,C.C., Zhang,J.,
Xiang,J.F., Yang,L. and Chen,L.L. (2016) Unusual processing
generates SPA LncRNAs that sequester multiple RNA binding
proteins.Mol. Cell, 64, 534–548.
87. Crespi,M.D., Jurkevitch,E., Poiret,M., d’Aubenton-Carafa,Y.,
Petrovics,G., Kondorosi,E. and Kondorosi,A. (1994) enod40, a gene
expressed during nodule organogenesis, codes for a non-translatable
RNA involved in plant growth. EMBO J., 13, 5099–5112.
88. Gultyaev,A.P. and Roussis,A. (2007) Identification of conserved
secondary structures and expansion segments in enod40 RNAs
reveals new enod40 homologues in plants. Nucleic Acids Res., 35,
3144–3152.
89. Campalans,A., Kondorosi,A. and Crespi,M. (2004) Enod40, a short
open reading frame – containing mRNA, induces cytoplasmic
localization of a nuclear RNA binding protein in Medicago
truncatula. Plant Cell, 16, 1047–1059.
Downloaded from https://academic.oup.com/nar/advance-article-abstract/doi/10.1093/nar/gky095/4841659
by guest
on 08 February 2018
Nucleic Acids Research, 2018 15
90. Khorkova,O., Myers,A.J., Hsiao,J. and Wahlestedt,C. (2014)
Natural antisense transcripts. Hum. Mol. Genet., 23, R54–63.
91. Krystal,G.W., Armstrong,B.C. and Battey,J.F. (1990) N-myc mRNA
forms an RNA-RNA duplex with endogenous antisense transcripts.
Mol. Cell. Biol., 10, 4180–4191.
92. Suenaga,Y., Islam,S.M.R., Alagu,J., Kaneko,Y., Kato,M.,
Tanaka,Y., Kawana,H., Hossain,S., Matsumoto,D., Yamamoto,M.
et al. (2014) NCYM, a cis-antisense gene of MYCN, encodes a de
novo evolved protein that inhibits GSK3 resulting in the
stabilization of MYCN in human neuroblastomas. PLoS Genet., 10,
e1003996.
93. Munroe,S.H. and Lazar,M.A. (1991) Inhibition of c-erbA mRNA
splicing by a naturally occurring antisense RNA. J. Biol. Chem., 266,
22083–22086.
94. Hastings,M.L., Milcarek,C., Martincic,K., Peterson,M.L. and
Munroe,S.H. (1997) Expression of the thyroid hormone receptor
gene, erbAalpha, in B lymphocytes: alternative mRNA processing is
independent of differentiation but correlates with antisense RNA
levels. Nucleic Acids Res., 25, 4296–4300.
95. Rindfleisch,B.C., Brown,M.S., VandeBerg,J.L. and Munroe,S.H.
(2010) Structure and expression of two nuclear receptor genes in
marsupials: insights into the evolution of the antisense overlap
between the -thyroid hormone receptor and Rev-erb. BMCMol.
Biol., 11, 97.
96. Bardou,F., Merchan,F., Ariel,F. and Crespi,M. (2011) Dual RNAs
in plants. Biochimie, 93, 1950–1954.
97. Villamizar,O., Chambers,C.B., Riberdy,J.M., Persons,D.A. and
Wilber,A. (2015) Long noncoding RNA Saf and splicing factor 45
increase soluble Fas and resistance to apoptosis. Oncotarget, 7, 1–17.
98. Beltran,M., Puig,I., Pen˜a,C., Garcı´a,J.M., A´lvarez,A.B., Pen˜a,R.,
Bonilla,F. and Herreros,A.G. De (2008) A natural antisense
transcript regulates Zeb2 / Sip1 gene expression during
Snail1-induced epithelial – mesenchymal transition. Genes Dev., 22,
756–769.
99. Massone,S., Vassallo,I., Fiorino,G., Castelnuovo,M., Barbieri,F.,
Borghi,R., Tabaton,M., Robello,M., Gatta,E., Russo,C. et al. (2011)
17A, a novel non-coding RNA, regulates GABA B alternative
splicing and signaling in response to inflammatory stimuli and in
Alzheimer disease. Neurobiol. Dis., 41, 308–317.
100. Luco,R.F., Allo,M., Schor,I.E., Kornblihtt,A.R. and Misteli,T.
(2011) Epigenetics in alternative pre-mRNA splicing. Cell, 144,
16–26.
101. Batsche´,E., Yaniv,M. and Muchardt,C. (2006) The human
SWI/SNF subunit Brm is a regulator of alternative splicing. Nat.
Struct. Mol. Biol., 13, 22–29.
102. Schor,I.E., Rascovan,N., Pelisch,F., Allo´,M. and Kornblihtt,A.R.
(2009) Neuronal cell depolarization induces intragenic chromatin
modifications affecting NCAM alternative splicing. Proc. Natl.
Acad. Sci. U.S.A., 106, 4325–4330.
103. Chen,L. (2016) The biogenesis and emerging roles of circular RNAs.
Nat. Rev. Mol. Cell Biol., 17, 205–211.
104. Ashwal-Fluss,R., Meyer,M., Pamudurti,N.R., Ivanov,A.,
Bartok,O., Hanan,M., Evantal,N., Memczak,S., Rajewsky,N. and
Kadener,S. (2014) circRNA biogenesis competes with pre-mRNA
splicing.Mol. Cell, 56, 55–66.
105. Conn,S.J., Pillman,K.A., Toubia,J., Conn,V.M., Salmanidis,M.,
Phillips,C.A., Roslan,S., Schreiber,A.W., Gregory,P.A. and
Goodall,G.J. (2015) The RNA binding protein quaking regulates
formation of circRNAs. Cell, 160, 1125–1134.
106. Kelly,S., Greenman,C., Cook,P.R. and Papantonis,A. (2015) Exon
skipping is correlated with exon circularization. J. Mol. Biol., 427,
2414–2417.
107. Conn,V.M., Hugouvieux,V., Nayak,A., Conos,S.A., Capovilla,G.,
Cildir,G., Jourdain,A., Tergaonkar,V., Schmid,M., Zubieta,C. et al.
(2017) A circRNA from SEPALLATA3 regulates splicing of its
cognate mRNA through R-loop formation. Nat. Plants, 3, 17053.
108. Ariel,F. and Crespi,M. (2017) Alternative splicing: the lord of the
rings. Nat. Plants, 3, 17065.
109. Gonzalez,I., Munita,R., Agirre,E., Dittmer,T. a, Gysling,K.,
Misteli,T. and Luco,R.F. (2015) A lncRNA regulates alternative
splicing via establishment of a splicing-specific chromatin signature.
Nat. Struct. Mol. Biol., 22, 370–376.
110. Yang,L., Lin,C., Liu,W., Zhang,J., Ohgi,K.A., Grinstein,J.D.,
Dorrestein,P.C. and Rosenfeld,M.G. (2011) NcRNA- and Pc2
methylation-dependent gene relocation between nuclear structures
mediates gene activation programs. Cell, 147, 773–788.
111. Clemson,C.M., Hutchinson,J.N., Sara,S.A., Ensminger,A.W.,
Fox,A.H., Chess,A. and Lawrence,J.B. (2009) An architectural role
for a nuclear noncoding RNA: NEAT1 RNA is essential for the
structure of Paraspeckles.Mol. Cell, 33, 717–726.
112. Mao,Y.S., Sunwoo,H., Zhang,B. and Spector,D.L. (2011) Direct
visualization of the co-transcriptional assembly of a nuclear body by
noncoding RNAs. Nat. Cell Biol., 13, 95–101.
113. Engreitz,J.M., Sirokman,K., McDonel,P., Shishkin,A.A., Surka,C.,
Russell,P., Grossman,S.R., Chow,A.Y., Guttman,M. and
Lander,E.S. (2014) RNA-RNA interactions enable specific targeting
of noncoding RNAs to nascent pre-mRNAs and chromatin sites.
Cell, 159, 188–199.
114. Ietswaart,R., Wu,Z. and Dean,C. (2012) Flowering time control:
another window to the connection between antisense RNA and
chromatin. Trends Genet., 28, 445–453.
115. Rodriguez-Granados,N.Y., Ramirez-Prado,J.S., Veluchamy,A.,
Latrasse,D., Raynaud,C., Crespi,M., Ariel,F. and Benhamed,M.
(2016) Put your 3D glasses on: plant chromatin is on show. J. Exp.
Bot., 67, 3205–3221.
116. Kim,D.H. and Sung,S. (2017) Vernalization-triggered intragenic
chromatin loop formation by long noncoding RNAs. Dev. Cell, 40,
302–312.
117. Zhou,H.-L., Luo,G., Wise,J.A. and Lou,H. (2014) Regulation of
alternative splicing by local histone modifications: potential roles for
RNA-guided mechanisms. Nucleic Acids Res., 42, 701–713.
118. West,J.A., Davis,C.P., Sunwoo,H., Simon,M.D., Sadreyev,R.I.,
Wang,P.I., Tolstorukov,M.Y. and Kingston,R.E. (2014) The long
noncoding RNAs NEAT1 and MALAT1 bind active chromatin
sites.Mol. Cell, 55, 791–802.
119. Simon,M.D., Pinter,S.F., Fang,R., Sarma,K.,
Rutenberg-Schoenberg,M., Bowman,S.K., Kesner,B.A., Maier,V.K.,
Kingston,R.E. and Lee,J.T. (2013) High-resolution Xist binding
maps reveal two-step spreading during X-chromosome inactivation.
Nature, 504, 465–469.
120. Misteli,T., Ca´ceres,J. and Spector,D. (1997) The dynamics of a
pre-mRNA splicing factor in living cells. Nature, 387, 523–527.
121. Zeng,C., Kim,E., Warren,S.L. and Berget,S.M. (1997) Dynamic
relocation of transcription and splicing factors dependent upon
transcriptional activity. EMBO J., 16, 1401–1412.
122. Huang,S. and Spector,D.L. (1996) Intron-dependent recruitment of
pre-mRNA splicing factors to sites of transcription. J. Cell Biol.,
133, 719–732.
123. Smith,K.P., Moen,P.T., Wydner,K.L., Coleman,J.R. and
Lawrence,J.B. (1999) Processing of endogenous pre-mRNAs in
association with SC-35 domains is gene specific. J. Cell Biol., 144,
617–629.
124. Jin,F., Li,Y., Dixon,J.R., Selvaraj,S., Ye,Z., Lee,A.Y., Yen,C.-A.,
Schmitt,A.D., Espinoza,C.A. and Ren,B. (2013) A high-resolution
map of the three-dimensional chromatin interactome in human cells.
Nature, 503, 290–294.
125. Engreitz,J.M., Pandya-Jones,A., McDonel,P., Shishkin,A.,
Sirokman,K., Surka,C., Kadri,S., Xing,J., Goren,A., Lander,E.S.
et al. (2013) The Xist lncRNA exploits three-dimensional genome
architecture to spread across the X chromosome. Science, 341,
1237973.
126. Tsai,M.-C., Manor,O., Wan,Y., Mosammaparast,N., Wang,J.K.,
Lan,F., Shi,Y., Segal,E. and Chang,H.Y. (2010) Long noncoding
RNA as modular scaffold of histone modification complexes.
Science, 329, 689–693.
127. van der Krol,A.R., Mur,L.A., Beld,M., Mol,J.N. and Stuitje,A.R.
(1990) Flavonoid genes in petunia: addition of a limited number of
gene copies may lead to a suppression of gene expression. Plant Cell,
2, 291–299.
128. Napoli,C., Lemieux,C. and Jorgensen,R. (1990) Introduction of a
chimeric chalcone synthase gene into petunia results in reversible
co-suppression of homologous genes in trans. Plant Cell, 2, 279–289.
129. Ha,M. and Kim,V.N. (2014) Regulation of microRNA biogenesis.
Nat. Rev. Mol. Cell Biol., 15, 509–524.
130. Taft,R.J., Glazov,E.A., Lassmann,T., Hayashizaki,Y., Carninci,P.
and Mattick,J.S. (2009) Small RNAs derived from snoRNAs. RNA,
15, 1233–1240.
Downloaded from https://academic.oup.com/nar/advance-article-abstract/doi/10.1093/nar/gky095/4841659
by guest
on 08 February 2018
16 Nucleic Acids Research, 2018
131. Thompson,D.M., Lu,C., Green,P.J. and Parker,R. (2008) tRNA
cleavage is a conserved response to oxidative stress in eukaryotes.
RNA, 14, 2095–2103.
132. Haussecker,D., Huang,Y., Lau,A., Parameswaran,P., Fire,A.Z. and
Kay,M.A. (2010) Human tRNA-derived small RNAs in the global
regulation of RNA silencing. RNA, 16, 673–695.
133. Catalanotto,C., Cogoni,C. and Zardo,G. (2016) MicroRNA in
control of gene expression: an overview of nuclear functions. Int. J.
Mol. Sci., 17, e1712.
134. Zhai,J., Bischof,S., Wang,H., Feng,S., Lee,T.F., Teng,C., Chen,X.,
Park,S.Y., Liu,L., Gallego-Bartolome,J. et al. (2015) A one
precursor one siRNA model for pol IV-dependent siRNA
biogenesis. Cell, 163, 445–455.
135. Duss,O., Michel,E., Yulikov,M., Schubert,M., Jeschke,G. and
Allain,F.H.-T. (2014) Structural basis of the non-coding RNA
RsmZ acting as a protein sponge. Nature, 509, 588–592.
136. Bayne,E.H., Portoso,M., Kagansky,A., Kos-Braun,I.C., Urano,T.,
Ekwall,K., Alves,F., Rappsilber,J. and Allshire,R.C. (2008) Splicing
factors facilitate RNAi-directed silencing in fission yeast. Science,
322, 602–606.
137. Chinen,M., Morita,M., Fukumura,K. and Tani,T. (2010)
Involvement of the spliceosomal U4 small nuclear RNA in
heterochromatic gene silencing at fission yeast centromeres. J. Biol.
Chem., 285, 5630–5638.
138. Ausin,I., Greenberg,M.V.C., Li,C.F. and Jacobsen,S.E. (2012) The
splicing factor SR45 affects the RNA-directed DNA methylation
pathway in Arabidopsis. Epigenetics, 7, 29–33.
139. Dou,K., Huang,C.F., Ma,Z.Y., Zhang,C.J., Zhou,J.X., Huang,H.W.,
Cai,T., Tang,K., Zhu,J.K. and He,X.J. (2013) The PRP6-like
splicing factor STA1 is involved in RNA-directed DNA methylation
by facilitating the production of Pol V-dependent scaffold RNAs.
Nucleic Acids Res., 41, 8489–8502.
140. Huang,C.F., Miki,D., Tang,K., Zhou,H.R., Zheng,Z., Chen,W.,
Ma,Z.Y., Yang,L., Zhang,H., Liu,R. et al. (2013) A
pre-mRNA-splicing factor is required for RNA-directed DNA
methylation in Arabidopsis. PLoS Genet., 9, e1003779.
141. Elvira-Matelot,E., Bardou,F., Ariel,F., Jauvion,V., Bouteiller,N., Le
Masson,I., Cao,J., Crespi,M.D. and Vaucheret,H. (2016) The
nuclear ribonucleoprotein SmD1 interplays with splicing, RNA
quality control and post-transcriptional gene silencing in
Arabidopsis. Plant Cell, 28, 426–438.
142. Spies,N., Nielsen,C.B., Padgett,R.A. and Burge,C.B. (2009) Biased
chromatin signatures around polyadenylation sites and exons.Mol.
Cell, 36, 245–254.
143. Schwartz,S., Meshorer,E. and Ast,G. (2009) Chromatin organization
marks exon-intron structure. Nat. Struct. Mol. Biol., 16, 990–995.
144. Andersson,R., Enroth,S., Rada-iglesias,A., Wadelius,C. and
Komorowski,J. (2009) Nucleosomes are well positioned in exons and
carry characteristic histone modifications. Genome Res., 19,
1732–1741.
145. Tilgner,H., Nikolaou,C., Althammer,S., Sammeth,M., Beato,M.,
Valca´rcel,J. and Guigo´,R. (2009) Nucleosome positioning as a
determinant of exon recognition. Nat. Struct. Mol. Biol., 16,
996–1001.
146. de la Mata,M., Lafaille,C. and Kornblihtt,A.R. (2010) First come,
first served revisited: factors affecting the same alternative splicing
event have different effects on the relative rates of intron removal.
RNA, 16, 904–912.
147. Kornblihtt,A.R. (2006) Chromatin, transcript elongation and
alternative splicing. Nat. Struct. Mol. Biol., 13, 5–7.
148. Allo´,M., Buggiano,V., Fededa,J.P., Petrillo,E., Schor,I., Mata,M.
De, Agirre,E., Plass,M., Eyras,E., Elela,S.A. et al. (2009) Control of
alternative splicing through siRNA-mediated transcriptional gene
silencing. Nat. Struct. Mol. Biol., 16, 717–725.
149. Schor,I.E., Fiszbein,A., Petrillo,E. and Kornblihtt,A.R. (2013)
Intragenic epigenetic changes modulate NCAM alternative splicing
in neuronal differentiation. EMBO J., 32, 2264–2274.
150. Ameyar-Zazoua,M., Rachez,C., Souidi,M., Robin,P., Fritsch,L.,
Young,R., Morozova,N., Fenouil,R., Descostes,N., Andrau,J.-C.
et al. (2012) Argonaute proteins couple chromatin silencing to
alternative splicing. Nat. Struct. Mol. Biol., 19, 998–1004.
151. Ko¨nig,H., Ponta,H. and Herrlich,P. (1998) Coupling of signal
transduction to alternative pre-mRNA splicing by a composite
splice regulator. EMBO J., 17, 2904–2913.
152. Ule,J., Jensen,K.B., Ruggiu,M., Mele,A., Ule,A. and Darnell,R.B.
(2003) CLIP identifies nova-regulated RNA networks in the brain.
Science, 302, 1212–1215.
153. Lambert,N., Robertson,A., Jangi,M., McGeary,S., Sharp,P.A. and
Burge,C.B. (2014) RNA Bind-n-Seq: quantitative assessment of the
sequence and structural binding specificity of RNA binding
proteins.Mol. Cell, 54, 887–900.
154. Sugimoto,Y., Chakrabarti,A.M., Luscombe,N.M. and Ule,J. (2017)
Using hiCLIP to identify RNA duplexes that interact with a specific
RNA-binding protein. Nat. Protoc., 12, 611–637.
155. Tan,D.S.W., Chong,F.T., Leong,H.S., Toh,S.Y., Lau,D.P.,
Kwang,X.L., Zhang,X., Sundaram,G.M., Tan,G.S., Chang,M.M.
et al. (2017) Long noncoding RNA EGFR-AS1 mediates epidermal
growth factor receptor addiction and modulates treatment response
in squamous cell carcinoma. Nat. Med., 23, 1167–1175.
Downloaded from https://academic.oup.com/nar/advance-article-abstract/doi/10.1093/nar/gky095/4841659
by guest
on 08 February 2018
